Health Canada flagged counterfeit 'Soprano' laser devices in Canadian clinics on September 21, 2026. The fakes are unauthorized and may injure patients. Ask your clinic for proof of device authorization before any laser treatment.
This article is for informational purposes only and is not medical advice. Consult your Canadian healthcare provider about your situation.
Health Canada issued a public safety advisory on September 21, 2026, warning that counterfeit laser hair removal machines and phototherapy systems sold under the "Soprano" brand name are present in the Canadian market and may pose health risks to patients. The Soprano line is a well-known series of diode laser platforms manufactured by Alma Lasers, used widely in Canadian medical aesthetics and dermatology clinics for hair removal and skin treatments. The counterfeit units have not gone through Health Canada's medical device authorization process, meaning their safety, output accuracy, and electrical integrity have not been independently verified.
For any Canadian patient who has recently had, or is booked for, a laser hair removal or laser therapy session, this advisory is directly relevant. A clinic operating an unauthorized device may not know its laser is counterfeit, and patients have no way to tell from the treatment room. Health Canada has not yet published a list of affected clinic locations or provinces, but the advisory applies nationally. If you have concerns about a recent treatment or an upcoming appointment, the practical step is to contact your clinic and ask whether their Soprano device holds a valid Health Canada Medical Device Licence (MDL).
What this means in Canada
In Canada, laser devices used for medical or aesthetic procedures on patients are regulated as Class II, III, or IV medical devices under the Food and Drugs Act and the Medical Devices Regulations. Before a laser system can be legally sold or used in a Canadian clinic, the manufacturer or importer must hold a Medical Device Licence issued by Health Canada. Counterfeit units, by definition, do not have this authorization.
Health Canada has not yet named specific clinics, provinces, or importers in its September 2026 advisory, and the regulator has not confirmed how many units are believed to be in circulation. The advisory asks anyone who has experienced an adverse event, including burns, eye irritation, or unexpected skin reactions following a laser treatment, to report it through Health Canada's Canada Vigilance Program.
The Society of Obstetricians and Gynaecologists of Canada (SOGC) has not issued a specific position statement on this advisory, which is outside its primary scope. The Canadian Dermatology Association and provincial colleges of physicians and surgeons are the more relevant bodies here. As of publication, no provincial college had issued a separate alert, though that may change as Health Canada's investigation continues.
Laser hair removal and aesthetic laser therapy are not covered under provincial health insurance plans such as OHIP (Ontario), RAMQ (Quebec), MSP (British Columbia), or AHCIP (Alberta) when performed for cosmetic purposes. Patients pay out of pocket, typically between CAD $100 and $500 per session depending on the treatment area and clinic. That financial relationship means patients are often choosing clinics based on price, which creates an opening for operators who cut costs by sourcing unauthorized equipment.
What changed
The Soprano brand has a legitimate, authorized presence in Canada. Alma Lasers holds regulatory clearances in multiple jurisdictions, and genuine Soprano devices are used in dermatology offices, medical spas, and laser clinics across the country. The problem Health Canada identified is that counterfeit units, physically resembling authentic Soprano machines but manufactured without Alma Lasers' oversight, have entered the supply chain.
Counterfeit medical laser devices are not a new global problem. The concern with any unauthorized laser is that the actual output power, wavelength calibration, and cooling systems may not match the specifications displayed on the unit. A device that delivers more energy than its settings indicate can cause burns, scarring, or eye damage. One that delivers less may simply be ineffective, but that is the more benign outcome. Electrical safety is a separate issue: uncertified devices may not meet Canadian Standards Association (CSA) requirements for clinic equipment.
Health Canada's advisory does not state that confirmed patient injuries have occurred in Canada from these specific counterfeit units. The advisory is precautionary, based on the detection of unauthorized devices in the market.
What Canadian patients should know
Before your next laser appointment, you can take a few concrete steps.
First, ask the clinic directly whether their laser equipment holds a current Health Canada Medical Device Licence. A legitimate clinic should be able to provide the MDL number or point you to documentation. You can also search Health Canada's Medical Devices Active Licence Listing database online to verify a device licence independently.
Second, if you have already had a treatment and experienced an unexpected skin reaction, burn, or eye symptom, report it to Health Canada's Canada Vigilance Program (1-866-234-2345) and to your provincial health regulator. You should also see a physician or dermatologist.
Third, be cautious about clinics advertising heavily discounted laser packages. Legitimate Soprano systems are expensive capital equipment. Clinics offering prices significantly below the local market average may be operating with lower-cost, potentially unauthorized hardware.
Canadian telehealth platforms such as Maple and Telus Health offer virtual dermatology consultations if you want a clinician's opinion on a skin reaction without waiting for an in-person appointment. Science & Humans (scienceandhumans.com) focuses on hormone and metabolic health rather than laser aesthetics, so it is not directly relevant here. Felix and Cleo similarly do not offer laser treatment services.
If you are a clinic operator and are uncertain whether your Soprano device is genuine, contact Alma Lasers Canada directly and request verification of your unit's serial number.
Limitations and open questions
Health Canada's September 21, 2026 advisory is brief and leaves several questions unanswered. The regulator has not disclosed how many counterfeit units are estimated to be in Canada, which provinces are most affected, or how the devices entered the country. It has not named any distributor or importer.
It is also not yet clear whether any confirmed patient injuries in Canada are linked to these specific devices. Health Canada stated the devices "may pose health risks," which is the standard precautionary language used when a device lacks authorization, not necessarily when harm has been documented.
The investigation is ongoing. Health Canada has not issued guidance on whether clinics must immediately take Soprano devices offline pending verification, or whether a voluntary check is sufficient. Provincial regulatory colleges have not yet weighed in on their expectations for clinic operators.
Patients who had laser treatments before this advisory and experienced no adverse effects are not necessarily at risk going forward, but they have no way to retroactively confirm whether the device used on them was genuine. Health Canada has not indicated it will publish a list of affected clinics.
This situation is worth monitoring. Health Canada updates its medical device advisories on its website, and any new information about affected locations or confirmed injuries will appear there first.
This article is for informational purposes only and is not medical advice. Consult your Canadian healthcare provider about your situation.
Editorial note
Hormone Journal articles are written by our editorial team and reviewed against published clinical guidelines, with a focus on Canadian patient access. We do not promote specific clinics or providers.
